Image (99678e1f Ed3c 48a8 8902 33f407eb0d8c 01)
Hydralazine Hydrochloride Injection
Product Images NDC 68475-514
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 68475-514). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Navinta Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Vial (99678e1f Ed3c 48a8 8902 33f407eb0d8c 02)
This text provides information about the storage conditions for a drug, including the temperature range for storage and the National Drug Code (NDC). It also mentions the dosage information and usage instructions for an injection solution in a single-dose vial. Additionally, it indicates the warning to discard any unused portion of the solution. The text includes contact details for the manufacturer or supplier located in Ewing, NJ, USA.*
Carton (99678e1f Ed3c 48a8 8902 33f407eb0d8c 03)
This text appears to be a product description of Hydralazine Hydrochloride Injection, USP. This medication is intended for intramuscular or intravenous use and comes in single-dose vials. It contains active ingredients including 20mg of Hydralazine Hydrochloride USP along with inactive components such as Propylene Glycol USP. It is recommended for emergency use in patients who are unable to take oral medications. The text also mentions specific dosages and storage conditions for the medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
